U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Earliest Event Reported: ~~October~~May 2531, ~~2018~~2019

Commission file number: 333-206839

HEALTH-RIGHT DISCOVERIES, INC.

(Exact name of registrant as specified in its charter)

Florida	45-3588650
(State or Other Jurisdiction of	(I.R.S. Employer
Incorporation or Organization)	Identification No.)

18851 NE 29th Avenue, Suite 700, Aventura, Florida 33180

(Address of Principal Executive Offices)

(305) 705-3247

(Registrant’s telephone number, including area code)

(Former name or address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions below:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240-14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Unless the context otherwise requires, all references in this Current Report on Form 8-K ~~report~~ to “HRD,” “Health-Right,” “the Company,” “we,” “our” and “us” refers to Health-Right Discoveries, Inc. and its subsidiaries.

Item 45.0102 ~~Change~~Departure inof ~~Registrant’s~~Directors ~~Certifying~~or ~~Accountant~~Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~(i)~~ In Onconsideration ~~October~~for 25David Hopkins, ~~2018~~the Company’s Chief Executive Officer and President, ~~Paritz~~assuming &the additional duties of President of the Company’s two subsidiaries, PCCI Billing, Inc.A. d/b/a complete Claim Management and Script Connection, LLC (collectively, the “~~Paritz~~Subsidiaries”), on May 31, 2019, the ~~independent~~Company ~~registered~~entered ~~public~~into ~~accounting~~an ~~firm~~amended and restated employment agreement with Mr. Hopkins, effective as of April 15, 2019 (the ~~Company~~“Effective Date”), ~~announced~~which ~~its~~superseded ~~resignation~~the ~~effective~~January 2018 onemployment agreement between the ~~same~~Company ~~date~~and Mr. AsHopkins. aThe ~~result,~~amended ~~the~~and ~~Company’s~~restated ~~Board~~employment ofagreement ~~Directors~~is ~~engaged~~for ~~Prager~~an initial ~~Metis~~term ~~CPAs~~of ~~LLC~~three (~~“Prager”~~3) toyears ~~serve~~from the Effective Date and automatically renews for additional three (3) year periods, provided that the Subsidiaries achieve combined Adjusted EBITDA (as determined by the Company'’s ~~independent~~accountants ~~registered~~from ~~public~~the ~~accounting~~Subsidiaries’ financial ~~firm~~statements ~~effective October~~used 25in preparing the Company’s audited financial statements) of $3,000,000 ~~2018~~for any calendar year during the initial term and any renewal term.

~~(ii)~~ The amended ~~reports~~and ofrestated ~~Paritz~~employment onagreement ~~the~~provides ~~financial~~for ~~statements~~an initial base salary of $250,000. In the ~~Company~~event asin ofany ~~and~~calendar ~~for~~year during the ~~fiscal~~initial ~~years~~term ~~ended~~or ~~December~~any 31renewal term, ~~2017~~the ~~and~~Subsidiaries ~~2016~~achieve combined Adjusted EBITDA (as determined by the Company’s ~~contained~~accountants nofrom ~~adverse~~the ~~opinion~~Subsidiaries’ orfinancial ~~disclaimer~~statements used in preparing the Company’s audited financial statements) of ~~opinion~~$3,000,000, ~~and~~Mr. ~~were~~Hopkins’ ~~not~~annual ~~qualified~~base orsalary ~~modified~~shall asautomatically increase to ~~uncertainty~~$300,000 ~~audit~~and ~~scope,~~in orthe ~~accounting principles,~~event ~~except~~in ~~that~~any calendar year during the ~~audit~~initial ~~reports~~term onor any renewal term, the ~~financial~~Subsidiaries ~~statements~~achieve ofcombined Adjusted EBITDA (as determined by the Company’s accountants ~~for~~from the ~~two~~Subsidiaries’ ~~fiscal~~financial ~~years~~statements ~~contained~~used anin ~~uncertainty about~~preparing the Company’s ~~ability~~audited financial statements) of $3,500,000, his annual base salary shall automatically increase to ~~continue~~$350,000. asMr. Hopkins will also receive a ~~going~~$600 ~~concern~~per month car allowance while the amended and restated employment agreement is in effect.

~~(iii)~~ The ~~During~~amended ~~the Company's fiscal years ended December 31, 2017~~ and ~~2016~~restated ~~and~~employment ~~the~~agreement ~~subsequent~~also ~~interim~~contains ~~period~~customary ~~from January 1~~confidentiality, ~~2018~~non-competition ~~to the date of this report,~~ and inchange connection with the audit of the Company's financial statements for such periods, there were no disagreements between the Company and Paritz on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Paritz, would have caused Paritz to make reference to the subject matter of such disagreements in ~~connection~~control ~~with its audit reports on the Company's financial statements~~provisions.

~~(iv)~~ The ~~During~~above ~~the~~summary ~~Company's~~of ~~fiscal~~the ~~years~~amended ~~ended December 31, 2017~~ and ~~2016~~restated ~~and~~employment ~~the~~agreement ~~subsequent~~is ~~interim~~qualified ~~period~~in ~~from~~its ~~January~~entirety 1,by ~~2018~~reference to the ~~date~~ copy of ~~this~~the ~~report,~~amended and ~~there~~restated ~~were~~employment noagreement ~~reportable~~filed ~~events~~as ~~within~~Exhibit ~~the~~10.1 ~~meaning~~to ofthis ~~Item~~report ~~304(a)(1)(v)~~and ofincorporated ~~Regulation~~herein ~~S-K~~by reference.

(v) During the Company's fiscal years December 31, 2017 and 2016 and the subsequent interim period from January 1, 2018 to the date of this report, the Company did not consult with Prager regarding any of the matters set forth in Items 304(a)(2)(i) and (ii) of Regulation S-K.

(vi) The Company has provided Paritz with a copy of the disclosures in this report and has requested that Paritz furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not Paritz agrees with the statements in this Item 4.01. A copy of this letter is filed as Exhibit 16.1 to this report.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description
16.1		Letter to Securities and Exchange Commission from Paritz & Company, P.A., dated October 31, 2018
10.1		Amended and Restated Employment Agreement with David Hopkins

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	HEALTH-RIGHT DISCOVERIES, INC.
Dated: October 31, 2018	By:	/s/ David Hopkins
Dated: June 3, 2019	By:	/s/ David Hopkins
		David Hopkins, President
		David Hopkins, Chief Executive Officer and President
		(Principal Executive, Financial and Accounting Officer)

Filing Compare · Health-Right Discoveries, Inc.